AlphaTON sells pharma subsidiary to focus on TON ecosystem

Nasdaq-listed AlphaTON, a firm managing a Digital Asset Treasury (DAT) of TON tokens, is selling its pharmaceutical subsidiary to concentrate on the Telegram blockchain ecosystem, The Block reported. The company has sold its biotech unit, iOx Therapeutics, to Immunova in a deal expected to generate up to $100 million in future revenue, including royalties.